CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-06 | MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. | Conversion | +5,504 | 5,504 | ||
| 2015-10-06 | MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. | Purchase | +100 | $11.00 | $1K | 6,504 |
| 2015-10-06 | MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. | Other acquisition | +357 | $7.24 | $3K | 6,861 |
| 2015-10-06 | MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. | Conversion · Series C-1 Convertible Preferred Stock | −7,530 | 0 | ||
| 2015-10-06 | Vaish Renu V.P., Global Reg. Affairs | Purchase | +350 | $11.00 | $4K | 350 |
| 2015-10-06 | Faleck Herbert J Chief Medical Officer | Purchase | +500 | $11.00 | $6K | 500 |
Page 18 of 18 · 346 trades